Qventus, Inc.

Based in the US, Qventus, Inc. is a technology firm specializing in AI-driven automation solutions that enhance operational efficiency in healthcare settings, streamlining care flows for hospitals and health systems. Qventus, Inc. is a technology company focused on AI-driven solutions for healthcare operations, founded in 2012 in Mountain View, California, US.

The company has undergone strategic developments but remains independently operated without subsidiaries. Founders Ian Christopher and Mudit Garg aimed to utilize artificial intelligence to solve critical operational challenges in healthcare. The latest funding round, Series D, raised USD 35. 809 mn, contributing to a total amount raised of USD 85.

000 mn, with the current company valuation at USD 431. 012 mn. The most recent deal occurred on January 13, 2025, and was led by KKR, alongside investors such as Allina Health System and Bessemer Venture Partners. Qventus specializes in AI-driven automation solutions tailored for healthcare organizations.

Its core offerings include the Qventus AI Platform, which leverages artificial intelligence, machine learning, and behavioral science to enhance care workflows. Key solutions comprise the Surgical Growth Solution for optimizing surgical volume, the Perioperative Care Coordination Solution that serves as an AI administrative assistant, and the Inpatient Capacity Solution that streamlines discharge planning. Qventus collaborates with diverse clients, including non-profit health systems like HonorHealth in Arizona, serving multiple regions across the United States. Qventus operates on a business-to-business (B2B) revenue model, where healthcare organizations subscribe to its automation solutions through long-term contracts.

Clients pay for software access based on their operational needs, often involving tiered pricing structures. The flagship offerings, particularly the Surgical Growth Solution and Perioperative Care Coordination Solution, are essential for driving revenue as they address significant operational challenges faced by hospitals. Strategic partnerships with health systems and hospitals support ongoing revenue generation. To support its future growth, Qventus plans to leverage funding from its recent USD 35.

809 mn Series D round to accelerate the development and commercialization of AI operational assistants. This includes expanding its solutions for both inpatient and outpatient settings and enhancing capabilities for surgical growth and inpatient capacity. The company aims to target new markets and geographic regions to establish a broader presence. As part of its growth strategy, Qventus is focused on releasing new products that will further streamline healthcare operations, with efforts set to advance throughout 2025.